RPg Family Wealth Advisory LLC Acquires Shares of 90 Intuitive Surgical, Inc. (NASDAQ:ISRG)

RPg Family Wealth Advisory LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, Holdings Channel reports. The firm bought 90 shares of the medical equipment provider’s stock, valued at approximately $44,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Kennedy Capital Management LLC acquired a new position in shares of Intuitive Surgical during the first quarter worth about $2,545,000. New Covenant Trust Company N.A. purchased a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $55,000. Citizens Financial Group Inc. RI lifted its holdings in shares of Intuitive Surgical by 62.0% in the 1st quarter. Citizens Financial Group Inc. RI now owns 2,075 shares of the medical equipment provider’s stock valued at $828,000 after buying an additional 794 shares during the period. LRI Investments LLC purchased a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. Finally, Swedbank AB acquired a new position in Intuitive Surgical during the first quarter worth $74,379,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now directly owns 821 shares in the company, valued at $402,519.88. This trade represents a 35.41 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,459 shares of company stock valued at $26,080,251. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $538.55 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $552.00. The stock has a fifty day moving average of $507.94 and a two-hundred day moving average of $466.79. The company has a market capitalization of $191.82 billion, a PE ratio of 86.58, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Mizuho boosted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Citigroup lifted their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. Leerink Partners lifted their price objective on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $526.06.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.